Parameter | E/A (lower is worse) | E/e’ (higher is worse) | e’/a’(lower is worse) | ||||||
---|---|---|---|---|---|---|---|---|---|
Estimate | SE | p value | Estimate | SE | p value | Estimate | SE | p value | |
Intercept | 1.919 | 0.156 | < .0001 | 1.458 | 0.158 | < .0001 | 2.283 | 0.165 | < .0001 |
Age at diagnosis | − 0.009 | 0.003 | 0.0043 | 0.000 | 0.003 | 0.9531 | − 0.020 | 0.003 | < .0001 |
Race—Caucasian | 0.002 | 0.026 | 0.9265 | − 0.038 | 0.026 | 0.1426 | − 0.007 | 0.027 | 0.8045 |
Sex—Female | − 0.045 | 0.026 | 0.0866 | 0.078 | 0.027 | 0.0033 | − 0.016 | 0.028 | 0.5567 |
DM Type—Type 1 | − 0.031 | 0.037 | 0.3926 | − 0.071 | 0.037 | 0.0570 | − 0.064 | 0.039 | 0.1000 |
DM duration (yr) | − 0.015 | 0.004 | 0.0002 | 0.006 | 0.004 | 0.1258 | − 0.023 | 0.004 | < .0001 |
Heart Rate (bpm) | − 0.009 | 0.001 | < .0001 | 0.001 | 0.001 | 0.3097 | − 0.009 | 0.001 | < .0001 |
Systolic BP z-score | 0.009 | 0.015 | 0.5573 | 0.039 | 0.015 | 0.0082 | − 0.013 | 0.015 | 0.3978 |
Diastolic BP z-score | − 0.010 | 0.017 | 0.5577 | 0.008 | 0.017 | 0.6371 | − 0.002 | 0.018 | 0.9161 |
Days of Vigorous activity | 0.006 | 0.006 | 0.2513 | 0.007 | 0.006 | 0.2118 | 0.003 | 0.006 | 0.6334 |
HbA1c (%) | − 0.010 | 0.005 | 0.0657 | − 0.006 | 0.005 | 0.2484 | 0.000 | 0.006 | 0.9865 |
LDL-C (mg/dl) | 0.000 | 0.000 | 0.3661 | 0.000 | 0.000 | 0.6358 | − 0.001 | 0.000 | 0.0656 |
HDL-C (mg/dl) | 0.000 | 0.001 | 0.8548 | 0.000 | 0.001 | 0.6698 | − 0.001 | 0.001 | 0.5657 |
Triglycerides (mg/dl) | − 0.021 | 0.022 | 0.3475 | 0.026 | 0.022 | 0.2375 | − 0.020 | 0.023 | 0.3911 |
BMI z-score | 0.007 | 0.016 | 0.6591 | 0.019 | 0.017 | 0.2484 | − 0.026 | 0.017 | 0.1297 |
LVM index | 0.000 | 0.002 | 0.8764 | 0.006 | 0.002 | 0.0001 | − 0.005 | 0.002 | 0.0051 |
PWV carotid femoral | − 0.046 | 0.011 | < .0001 | − 0.015 | 0.011 | 0.1712 | − 0.028 | 0.011 | 0.0168 |
Model R2 | 0.47 | 0.31 | 0.48 |